ACE Inhibitors Lower Pneumonia Threat

APRIL 01, 2005

Patients who have had a stroke can ward off the risk of pneumonia with angiotensin-converting enzyme (ACE) inhibitors. For the study, the researchers evaluated the risk of pneumonia in >1000 patients who had had a stroke. The patients involved in the 35-month study were given 1 of 3 treatments: ACE inhibitors, other blood pressure drugs, or a placebo. The data showed 2.8% of the ACE inhibitor group developed pneumonia, compared with 8.5% of the patients in the other 2 groups. (The findings were reported in Neurology, February 9, 2005.)



SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.